From: Biomarker enhanced risk prediction for development of AKI after cardiac surgery
 | AKI (15) | No AKI (32) | P value |
---|---|---|---|
Age | 68 ± 11 | 67 ± 11 | 0.72 |
Male:Female | 9:7 | 21:14 | 0.61 |
White:Black | 11:4 | 29:5 | 0.20 |
Risk Factor Score | 7.1 ±1.5 | 5.9 ± 1.1 | 0.005 |
CHF | 8 (53) | 25 (78) | 0.083 |
DM | 8 (53) | 18 (56) | 0.85 |
COPD | 4 (27) | 13 (41) | 0.44 |
CKD | 12 (80) | 17 (53) | 0.12 |
HTN | 15 (100) | 25 (78) | 0.068 |
CVA | 2 (13) | 3 (9.4) | 0.71 |
PVD | 1 (6.7) | 4 (13) | 0.50 |
Pre-Op Creatinine (mg/dl) | 2.1 ± 0.72 | 1.4 ± 0.59 | 0.002 |
Peak Creatinine (mg/dl) | 3.4 ± 1.14 | 1.7 ± 0.62 | <0.001 |
ACEI/ARB | 3 | 16 | 0.026 |
Pre-Op SBP (mm/Hg) | 141 ± 28 | 140 ± 21 | 0.91 |
Pre-Op DBP (mm/Hg) | 78 ± 18.2 | 76 ± 13 | 0.71 |
6 hr SBP (mm/Hg) | 106 ± 16 | 112 ± 16 | 0.25 |
6 hr DBP (mm/Hg) | 51 ± 10 | 58 ± 21 | 0.23 |
CABG:valve:both | 4:4:6 | 5:18:9 | 0.24 |
Urine Output 1st 6 hr (ml) | 444 ± 352 | 518± 223 | 0.40 |
Urine Output 1st 24 hr (ml) | 1256 ± 598 | 1567 ± 821 | 0.21 |
AKI Stage 1/2/3 | 13/2/0 | Â | Â |